August 7, 2013
A newly-published study has revealed that Merck & Co., the corporate mastermind behind the infamous Gardasil vaccine for human papillomavirus (HPV), conveniently forgot to research the effects of this deadly vaccine on women’s reproductive systems. And at least one young woman, in this case from Australia, bore the brunt of this inexcusable failure after discovering that her own ovaries had been completely destroyed as a result of getting the vaccine.
Published in the peer-reviewed British Medical Journal (BMJ), the harrowing recount of this young 16-year-old girl’s experience should give pause to all parents currently being pressured by their doctors into having their young daughters jabbed with Gardasil. Robbed of her natural ability to experience full womanhood, this young woman experienced early menopause, in which her ovaries completely shut down before they were even able to fully develop.
Entitled Premature ovarian failure 3 years after menarche in a 16-year-old girl following human papillomavirus vaccination, this latest case study provides solid evidence that Gardasil is, at the very least, a serious threat to normal ovarian function. Not only was the damaged girl examined and verified to have had healthy ovaries prior to the shots, but there were no other identified factors besides Gardasil that could have possibly been involved in her sudden ill-fate.
Worse is the fact that information later obtained from the Australian Therapeutic Goods Administration (TGA) for the case — TGA is Australia’s equivalent of the Food and Drug Administration (FDA) in the U.S. — revealed that Merck had never even conducted safety testing on Gardasil in relation to its effects on women’s ovaries. According to the report, Merck had only tested Gardasil’s effects on male testes.
“Although the TGA’s Australian Public Assessment Report for Human Papillomavirus Quadrivalent Vaccine, February 2011, does report on the histology of vaccinated rat testes and epididymides, no histological report has been available for vaccinated rat ovaries,” explains the report. “[A] histological report of the ovaries of vaccinated rats remained unavailable beyond a numbering of the corpora lutea present at postweaning euthanasia following the first litter.”
In other words, Merck either intentionally or accidentally — either option is completely unacceptable, by the way — failed to check whether or not Gardasil has the potential to damage young women’s reproductive systems, even though young women have always been the primary target market for the vaccine. Only recently have young boys been pulled into the Gardasil fray, despite the fact that the long-term side effects of the vaccine in males is still largely unknown.